Kroep JR - Search Results

1

Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer.

Dekker TJ, van de Velde CJ, van Bruggen D, Mesker WE, van der Hoeven JJ, Kroep JR, Tollenaar RA, Smit VT. Dekker TJ, et al. Among authors: kroep jr. Ann Oncol. 2013 Dec;24(12):2994-8. doi: 10.1093/annonc/mdt400. Epub 2013 Oct 10. Ann Oncol. 2013. PMID: 24114856 Free article.

2

Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors.

van Moorsel CJ, Kroep JR, Pinedo HM, Veerman G, Voorn DA, Postmus PE, Vermorken JB, van Groeningen CJ, van der Vijgh WJ, Peters GJ. van Moorsel CJ, et al. Among authors: kroep jr. Ann Oncol. 1999 Apr;10(4):441-8. doi: 10.1023/a:1008301522349. Ann Oncol. 1999. PMID: 10370787 Free article. Clinical Trial.

3

Experimental drugs and drug combinations in pancreatic cancer.

Kroep JR, Pinedo HM, van Groeningen CJ, Peters GJ. Kroep JR, et al. Ann Oncol. 1999;10 Suppl 4:234-8. Ann Oncol. 1999. PMID: 10436830 Review.

4

Gemcitabine-cisplatin: a schedule finding study.

Kroep JR, Peters GJ, van Moorsel CJ, Catik A, Vermorken JB, Pinedo HM, van Groeningen CJ. Kroep JR, et al. Ann Oncol. 1999 Dec;10(12):1503-10. doi: 10.1023/a:1008339425708. Ann Oncol. 1999. PMID: 10643544 Free article. Clinical Trial.

5

Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer.

Kroep JR, Pinedo HM, Giaccone G, Van Bochove A, Peters GJ, Van Groeningen CJ. Kroep JR, et al. Ann Oncol. 2004 Feb;15(2):230-5. doi: 10.1093/annonc/mdh063. Ann Oncol. 2004. PMID: 14760114 Free article. Clinical Trial.

6

Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer.

De Lange SM, van Groeningen CJ, Kroep JR, Van Bochove A, Snijders JF, Peters GJ, Pinedo HM, Giaccone G. De Lange SM, et al. Among authors: kroep jr. Ann Oncol. 2004 Mar;15(3):484-8. doi: 10.1093/annonc/mdh109. Ann Oncol. 2004. PMID: 14998853 Free article. Clinical Trial.

7

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

Kroep JR, Ouali M, Gelderblom H, Le Cesne A, Dekker TJA, Van Glabbeke M, Hogendoorn PCW, Hohenberger P. Kroep JR, et al. Ann Oncol. 2011 Jan;22(1):207-214. doi: 10.1093/annonc/mdq338. Epub 2010 Jul 23. Ann Oncol. 2011. PMID: 20656792 Free PMC article.

8

Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.

Kroep JR, Linn SC, Boven E, Bloemendal HJ, Baas J, Mandjes IA, van den Bosch J, Smit WM, de Graaf H, Schröder CP, Vermeulen GJ, Hop WC, Nortier JW. Kroep JR, et al. Neth J Med. 2010 Sep;68(9):371-6. Neth J Med. 2010. PMID: 20876920 Free article.

9

Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.

van de Ven S, Smit VT, Dekker TJ, Nortier JW, Kroep JR. van de Ven S, et al. Among authors: kroep jr. Cancer Treat Rev. 2011 Oct;37(6):422-30. doi: 10.1016/j.ctrv.2010.11.006. Epub 2010 Dec 21. Cancer Treat Rev. 2011. PMID: 21177040 Review.

10

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach.

Dekker TJ, Borg ST, Hooijer GK, Meijer SL, Wesseling J, Boers JE, Schuuring E, Bart J, van Gorp J, Mesker WE, Kroep JR, Smit VT, van de Vijver MJ. Dekker TJ, et al. Among authors: kroep jr. Breast Cancer Res. 2012 Jun 13;14(3):R93. doi: 10.1186/bcr3208. Breast Cancer Res. 2012. PMID: 22694844 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters